Efficacy and safety of agomelatine 25-50 mg/day versus...

European Neuropsychopharmacology 2017 / 10 Vol. 27

Efficacy and safety of agomelatine 25-50 mg/day versus escitalopram 10-20 mg/day in severe generalized anxiety disorder

Stein, D.J., Khoo, J.P., Van Ameringen, D.M., Hoschl, C., Ahokas, A., Bauer, M., Bitter, I., Jarema, M., Mosolov, S., Vavrusova, L., Picarel-Blanchot, F., Matharan, S., Olivier, V.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
European Neuropsychopharmacology
DOI:
10.1016/s0924-977x(17)31762-5
Date:
October, 2017
File:
PDF, 69 KB
english, 2017
Conversion to is in progress
Conversion to is failed